Literature DB >> 30900968

Pursuing parity: genetic tests for psychiatric conditions in the UK National Health Service.

David Curtis1, Katherine Adlington2, Kamaldeep S Bhui3.   

Abstract

Schizophrenia and anorexia nervosa were recently added to the list of conditions for which whole genome sequencing might be indicated as part of the 100 000 Genomes Project, reflecting the remarkable recent progress in findings emerging from psychiatric genetics research. Genetic testing methods may offer increased opportunities for diagnosis and estimation of familial risk and could have implications for management and treatment options. They also present ethical and philosophical questions about the role of testing and storage of genetic information. Mental health professionals will need to have a good understanding of this area in order for patients to fully realise the benefits of these advances.Declaration of InterestK.S.B. is Editor of the British Journal of Psychiatry.

Entities:  

Keywords:  Genetics; anorexia nervosa; schizophrenia

Mesh:

Year:  2019        PMID: 30900968     DOI: 10.1192/bjp.2019.48

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  3 in total

1.  Assessment of Potential Clinical Role for Exome Sequencing in Schizophrenia.

Authors:  Thivia Balakrishna; David Curtis
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

2.  A next generation sequencing gene panel for use in the diagnosis of anorexia nervosa.

Authors:  Maria Rachele Ceccarini; Vincenza Precone; Elena Manara; Stefano Paolacci; Paolo Enrico Maltese; Valentina Benfatti; Kristjana Dhuli; Kevin Donato; Giulia Guerri; Giuseppe Marceddu; Pietro Chiurazzi; Laura Dalla Ragione; Tommaso Beccari; Matteo Bertelli
Journal:  Eat Weight Disord       Date:  2021-11-25       Impact factor: 4.652

Review 3.  Genetic contributions to the etiology of anorexia nervosa: New perspectives in molecular diagnosis and treatment.

Authors:  Stefano Paolacci; Aysha Karim Kiani; Elena Manara; Tommaso Beccari; Maria Rachele Ceccarini; Liborio Stuppia; Pietro Chiurazzi; Laura Dalla Ragione; Matteo Bertelli
Journal:  Mol Genet Genomic Med       Date:  2020-05-05       Impact factor: 2.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.